MicroRNA-133b alleviates doxorubicin-induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2

Doxorubicin is one of the most important chemotherapeutic drugs for the treatment of malignant tumors, but the cardiotoxicity of doxorubicin severely limits its clinical application. Increasing numbers of microRNAs (miRNAs/miRs) have been found to be dysregulated in doxorubicin-treated cardiomyocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen, Ye, Zekang, Ma, Jiazheng, Gu, Qian, Teng, Jianzhen, Gong, Xiaoxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128419/
https://www.ncbi.nlm.nih.gov/pubmed/33982775
http://dx.doi.org/10.3892/ijmm.2021.4958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128419/
https://www.ncbi.nlm.nih.gov/pubmed/33982775
http://dx.doi.org/10.3892/ijmm.2021.4958

Ejemplares similares